Media Image Professor Kevin Harrington: Targeted Physical Therapies Theme Lead 40 per cent of patients whose cancers are cured receive radiotherapy, while surgery remains the intervention with the greatest prospect of cure as a standalone treatment. This theme focuses on research into image-guided radiotherapy to reduce the incidence of treatment-related side effects and image-guided surgery to optimise tumour and regional lymph node resections. Research into high-intensity focused ultrasound, which has significant potential for patients who are not able to undergo surgery and for whom radiotherapy may not be possible, is another focus of this theme. Theme aims To develop real-time image-guided treatments that allow increased effectiveness in removing primary tumours and loco-regional lymph node metastases while simultaneously reducing damage to surrounding normal tissues To reduce treatment-related side effects for radiotherapy To enhance patient experience, optimise patient recovery times, improve quality and safety of minimally invasive surgery and improve surgical outcomes To integrate these approaches with new immunotherapies, testing the ability of highly targeted, localised treatments to trigger systemic anti-tumour effects Theme Lead Professor Kevin Harrington (pictured above): Joint Head of the Division of Radiotherapy and Imaging at The Institute of Cancer Research, expertise in head and neck cancer and melanoma.
Our impact: Targeted Physical Therapies Supporting research into targeted therapies such as radiotherapy, surgery and high-intensity focused ultrasound, we aim to increase cure rates and decrease the incidence of treatment-related side effects. Find out more
Pioneering prostate cancer trial launched to see if radiotherapy can be safely received in two large doses
